Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:NAOV NASDAQ:NXL NASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$2.20+3.4%$2.61$1.98▼$22.25$17.31M-0.4663,579 shs46,265 shsNAOVNanovibronix$5.20-0.2%$7.84$4.71▼$162.50$4.14M2.09134,241 shs27,956 shsNXLNexalin Technology$0.84-1.6%$0.96$0.59▼$4.49$14.56M3.682.85 million shs149,049 shsOSRHOSR$0.58-3.0%$0.88$0.45▼$13.40$12.41M1.5113.91 million shs183,963 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies+3.43%+1.99%-22.16%-18.41%-85.86%NAOVNanovibronix-0.19%-4.76%-37.65%-42.22%-91.73%NXLNexalin Technology-1.64%-12.57%-15.55%-35.19%-9.32%OSRHOSR-3.00%-25.95%-13.01%-57.72%+57,499,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$2.20+3.4%$2.61$1.98▼$22.25$17.31M-0.4663,579 shs46,265 shsNAOVNanovibronix$5.20-0.2%$7.84$4.71▼$162.50$4.14M2.09134,241 shs27,956 shsNXLNexalin Technology$0.84-1.6%$0.96$0.59▼$4.49$14.56M3.682.85 million shs149,049 shsOSRHOSR$0.58-3.0%$0.88$0.45▼$13.40$12.41M1.5113.91 million shs183,963 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies+3.43%+1.99%-22.16%-18.41%-85.86%NAOVNanovibronix-0.19%-4.76%-37.65%-42.22%-91.73%NXLNexalin Technology-1.64%-12.57%-15.55%-35.19%-9.32%OSRHOSR-3.00%-25.95%-13.01%-57.72%+57,499,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.50Moderate Buy$22.83936.47% UpsideNAOVNanovibronix 0.00N/AN/AN/ANXLNexalin Technology 3.00Buy$5.00498.01% UpsideOSRHOSR 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NAOV, ALUR, OSRH, and NXL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/12/2025ALURAllurion TechnologiesZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$32.11M0.53N/AN/A($30.08) per share-0.07NAOVNanovibronix$2.56M1.63N/AN/A$18.38 per share0.28NXLNexalin Technology$170K85.68N/AN/A$0.28 per share2.99OSRHOSRN/AN/AN/AN/A($3.87) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$7.20M-$12.53N/AN/AN/A-158.30%N/A-59.91%11/12/2025 (Estimated)NAOVNanovibronix-$3.70M-$13.53N/A∞N/A-380.29%-45.24%-34.24%11/12/2025 (Estimated)NXLNexalin Technology-$7.61M-$0.76N/A∞N/A-5,057.14%-209.20%-186.87%N/AOSRHOSR-$2.41MN/A0.00∞N/AN/A-12.19%-8.18%N/ALatest NAOV, ALUR, OSRH, and NXL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025ALURAllurion Technologies-$0.65-$0.57+$0.08-$1.28$6.20 million$3.38 million8/19/2025Q2 2025NAOVNanovibronixN/A-$1.03N/A-$1.03N/A$0.49 million8/14/2025Q2 2025OSRHOSRN/A$0.02N/A$0.02N/A$1.14 million8/6/2025Q2 2025NXLNexalin Technology-$0.14-$0.10+$0.04-$0.10$0.04 million$0.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/ANAOVNanovibronixN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A2.021.70NAOVNanovibronixN/A1.050.72NXLNexalin TechnologyN/A10.4310.14OSRHOSRN/A0.180.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%NAOVNanovibronix16.39%NXLNexalin Technology0.65%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies22.40%NAOVNanovibronix6.30%NXLNexalin Technology25.26%OSRHOSR33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies5017.76 million6.02 millionOptionableNAOVNanovibronix20800,000747,000Not OptionableNXLNexalin Technology317.42 million13.02 millionNot OptionableOSRHOSRN/A21.58 million14.32 millionN/ANAOV, ALUR, OSRH, and NXL HeadlinesRecent News About These CompaniesOSR Holdings Amends Note Purchase AgreementAugust 20, 2025 | tipranks.comLatest OSR Holdings Stock News | NASDAQ:OSRH | BenzingaAugust 9, 2025 | benzinga.comOSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025August 1, 2025 | prnewswire.comOSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share ...August 1, 2025 | morningstar.comMOSR Holdings Inc.: OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange StructureAugust 1, 2025 | finanznachrichten.deOSR Holdings Reveals Update on Woori IO Deal and Share ExchangeAugust 1, 2025 | msn.comOSR Holdings Provides Transparency Update on Equity Financing InstrumentsJuly 31, 2025 | prnewswire.comOSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange StructureJuly 30, 2025 | prnewswire.comOSR Holdings to acquire South Korea’s medical device company Woori IOJuly 28, 2025 | finance.yahoo.comOSR Holdings enters term sheet to acquire Woori IO (OSRH:NASDAQ)July 25, 2025 | seekingalpha.comOSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in ...July 25, 2025 | seekingalpha.comOSR Holdings signs term sheet to acquire noninvasive glucose tech firmJuly 25, 2025 | investing.comOSR Holdings signs term sheet to acquire South Korea-based noninvasive glucose monitoring technology company, Woori IOJuly 25, 2025 | pharmabiz.comPOSR Holdings enters term sheet to acquire Woori IOJuly 24, 2025 | msn.comOSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring TechnologyJuly 24, 2025 | prnewswire.comOSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR CompanyJuly 15, 2025 | prnewswire.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D ...July 11, 2025 | taiwannews.com.twTOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG | MorningstarJuly 9, 2025 | morningstar.comMOSR Holdings plans $50 million security token offering in 2025July 9, 2025 | uk.investing.comOSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AGJuly 9, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAOV, ALUR, OSRH, and NXL Company DescriptionsAllurion Technologies NYSE:ALUR$2.20 +0.07 (+3.43%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$2.15 -0.05 (-2.18%) As of 09/5/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Nanovibronix NASDAQ:NAOV$5.20 -0.01 (-0.19%) Closing price 09/5/2025 03:55 PM EasternExtended Trading$5.11 -0.09 (-1.73%) As of 09/5/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Nexalin Technology NASDAQ:NXL$0.84 -0.01 (-1.64%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.84 +0.00 (+0.35%) As of 09/5/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.OSR NASDAQ:OSRH$0.57 -0.02 (-3.00%) As of 09/5/2025 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
